Shopping Cart 0
Cart Subtotal
AED 0

Hitachi Chemical Co Ltd (4217) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Hitachi Chemical Co., Ltd. (Hitachi Chemical), a subsidiary of Hitachi, Ltd, is a chemical manufacturer. It carries out the manufacture and sale of advanced components and systems such as energy storage devices and systems, and electronic components. The company's product portfolio includes electronics materials, inorganic materials, polymer science materials, semiconductor and display related materials; printed wiring boards and related products; carbon and ceramic; automotive products; and advanced functional films. Hitachi Chemical owns and operates manufacturing facilities in Japan, China, Indonesia, the US and Mexico, among others. Through its subsidiaries and affiliated companies, the company distributes products in Japan and other parts of Asia, Europe and the US. Hitachi Chemical is headquartered in Chiyoda-ku, Tokyo, Japan.

Hitachi Chemical Co Ltd (4217)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Hitachi Chemical and University of Texas MD Anderson Cancer Center Enter into Agreement 11

Licensing Agreements 12

Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12

Acquisition 13

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13

Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15

Hitachi Chemical Co Ltd-Key Competitors 16

Hitachi Chemical Co Ltd-Key Employees 17

Hitachi Chemical Co Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 21

Strategy And Business Planning 21

Oct 19, 2017: PCT Establishes Global Contract Development and Manufacturing Services Platform 21

Oct 10, 2017: PCT GMP Manufacturing Infrastructure and Cleanroom Capacity Expands to Support Clients through Commercial Stage 22

Other Significant Developments 23

Sep 21, 2017: PCT to Become the Manufacturing and Development Service Platform of Hitachi Chemical Advanced Therapeutics Solutions 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hitachi Chemical and University of Texas MD Anderson Cancer Center Enter into Agreement 11

Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13

Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15

Hitachi Chemical Co Ltd, Key Competitors 16

Hitachi Chemical Co Ltd, Key Employees 17

Hitachi Chemical Co Ltd, Other Locations 18

Hitachi Chemical Co Ltd, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Hitachi Chemical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Hitachi Chemical Co., Ltd. (Hitachi Chemical), a subsidiary of Hitachi, Ltd, is a chemical manufacturer. It carries out the manufacture and sale of advanced components and systems such as energy storage devices and systems, and electronic components. The company's product portfolio includes electronics materials, inorganic materials, polymer science materials, semiconductor and display related materials; printed wiring boards and related products; carbon and ceramic; automotive products; and advanced functional films. Hitachi Chemical owns and operates manufacturing facilities in Japan, China, Indonesia, the US and Mexico, among others. Through its subsidiaries and affiliated companies, the company distributes products in Japan and other parts of Asia, Europe and the US. Hitachi Chemical is headquartered in Chiyoda-ku, Tokyo, Japan.

Hitachi Chemical Co Ltd (4217)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Hitachi Chemical and University of Texas MD Anderson Cancer Center Enter into Agreement 11

Licensing Agreements 12

Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12

Acquisition 13

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13

Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15

Hitachi Chemical Co Ltd-Key Competitors 16

Hitachi Chemical Co Ltd-Key Employees 17

Hitachi Chemical Co Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 21

Strategy And Business Planning 21

Oct 19, 2017: PCT Establishes Global Contract Development and Manufacturing Services Platform 21

Oct 10, 2017: PCT GMP Manufacturing Infrastructure and Cleanroom Capacity Expands to Support Clients through Commercial Stage 22

Other Significant Developments 23

Sep 21, 2017: PCT to Become the Manufacturing and Development Service Platform of Hitachi Chemical Advanced Therapeutics Solutions 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hitachi Chemical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Hitachi Chemical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Hitachi Chemical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hitachi Chemical and University of Texas MD Anderson Cancer Center Enter into Agreement 11

Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13

Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15

Hitachi Chemical Co Ltd, Key Competitors 16

Hitachi Chemical Co Ltd, Key Employees 17

Hitachi Chemical Co Ltd, Other Locations 18

Hitachi Chemical Co Ltd, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Hitachi Chemical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat